Intrexon | XON - Biaya Penjualan





Biaya Penjualan Perubahan Tanggal
Agenus USD 642K 399K 2025-09
Alaunos Therapeutics USD 0 18K 2024-09
Amgen USD 1.6B 187M 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Incyte USD 104.5M 16.68M 2026-03
Intrexon USD 1.01M 344K 2024-06
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
MannKind USD 33.65M 13.44M 2025-12
Merck USD 2.94B 380M 2026-03
Novartis USD 3.46B 83M 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Veracyte USD 39.28M 1.93M 2025-12
Xencor USD 61.66M 50.95M 2025-06